Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1992; Volume 262,Issue 3
  • You have access
    Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.
    A Szallasi, N E Lewin and P M Blumberg
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 883-888;
  • You have access
    Sympathoadrenal contribution to nicotinic and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat.
    F J Miao, N L Benowitz, A I Basbaum and J D Levine
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 889-895;
  • You have access
    Identification of the mixed disulfide of glutathione and cysteinylglycine in bile: dependence on gamma-glutamyl transferase and responsiveness to oxidative stress.
    C Madhu, Z Gregus, C C Cheng and C D Klaassen
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 896-900;
  • You have access
    Effect of chlorethylclonidine on arterial blood pressure and heart rate in the conscious rat.
    M T Piascik, M S Sparks and T A Pruitt
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 901-906;
  • You have access
    Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey.
    L L Howell and L D Byrd
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 907-915;
  • You have access
    Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
    E A Kowaluk, P Seth and H L Fung
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 916-922;
  • You have access
    Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
    S B Pruett, Y C Han and B A Fuchs
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 923-928;
  • You have access
    Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    B Levant, D E Grigoriadis and E B DeSouza
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 929-935;
  • You have access
    Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats.
    S R Tella, G R Korupolu, C W Schindler and S R Goldberg
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 936-946;
  • You have access
    Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
    B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;
  • You have access
    Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.
    L M Renzetti, A Shenvi and C K Buckner
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 957-963;
  • You have access
    Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
    E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;
  • You have access
    2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
    E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;
  • You have access
    [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
    S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;
  • You have access
    Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
    B Gout, J Jean and A Bril
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 987-994;
  • You have access
    Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice.
    F L Smith and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 995-1003;
  • You have access
    Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
    P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;
  • You have access
    Epileptogenesis reduces the sensitivity of presynaptic gamma-aminobutyric acidB receptors on glutamatergic afferents in the amygdala.
    E K Asprodini, D G Rainnie and P Shinnick-Gallagher
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1011-1021;
  • You have access
    Effect of transient vagal cold blockade upon reflex actions of a polar and nonpolar cardiac glycoside.
    R W Caldwell and W R Rebagay
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1022-1027;
  • You have access
    Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum.
    W M Mack, I Zimányi and I N Pessah
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1028-1037;
  • You have access
    Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
    C S Aulakh, J L Hill, K P Lesch and D L Murphy
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1038-1043;
  • You have access
    Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    C G Pick, D Paul and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1044-1050;
  • You have access
    Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    S D Comer, T F Burke, J W Lewis and J H Woods
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1051-1056;
  • You have access
    Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
    D G May, R J Naukam, J R Kambam and R A Branch
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1057-1061;
  • You have access
    Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
    S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;
  • You have access
    Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
    D W Fink, P T Horn and B L Mirkin
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1070-1075;
  • You have access
    Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion.
    J S Pasnani and G R Ferrier
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1076-1084;
  • You have access
    Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.
    R Kuczenski and D S Segal
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1085-1094;
  • You have access
    Guinea pig gall bladder contains a single peptide leukotriene receptor which resembles that present in human conducting airway smooth muscle.
    R C Falcone and R D Krell
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1095-1102;
  • You have access
    Effects of renal denervation on sodium balance and renal function during chronic furosemide administration in rats.
    J S Petersen and G F DiBona
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1103-1109;
  • You have access
    Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
    N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;
  • You have access
    Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;
  • You have access
    Dietary choline supplementation increases the density of nicotine binding sites in rat brain.
    J B Coutcher, G Cawley and L Wecker
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1128-1132;
  • You have access
    Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats.
    R Yamamoto, K Takasaki and G A Nickols
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1133-1138;
  • You have access
    Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
    N C Turner and L J Wood
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1139-1146;
  • You have access
    Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.
    D W Snyder, C D Sommers, J L Bobbitt and E D Mihelich
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1147-1153;
  • You have access
    Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
    J A Keiser, F A Bjork, J C Hodges and D G Taylor
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1154-1160;
  • You have access
    Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
    C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;
  • You have access
    Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;
  • You have access
    Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential.
    J T Eells, P A Bandettini, P A Holman and J M Propp
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1173-1181;
  • You have access
    L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine transport in rat liver canalicular membrane vesicles: potential reabsorption mechanisms for biliary metabolites of glutathione and its S-conjugates.
    T W Simmons, M W Anders and N Ballatori
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1182-1188;
  • You have access
    Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium.
    M Takanashi and M Endoh
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1189-1194;
  • You have access
    Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
    D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;
  • You have access
    Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    E Vallée, E Azoulay-Dupuis, J Bauchet and J J Pocidalo
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1203-1208;
  • You have access
    Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
    K Morita, M Azuma, S Hamano, M Oka and K Teraoka
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;
  • You have access
    Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
    R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;
  • You have access
    Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.
    R Lelchuk, M W Radomski, J F Martin and S Moncada
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1220-1224;
  • You have access
    Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone.
    P Khanna, S Kaur, G G Sanwal and B Ali
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1225-1231;
  • You have access
    Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia.
    D L Wolgin and G G Kinney
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1232-1241;
  • You have access
    Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells.
    G W Dorn and M G Davis
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1242-1247;
  • You have access
    Characterization and localization of leukotriene C4 receptors in bullfrog lung.
    M Chiono, J J Andazola, O A Torres and C A Herman
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1248-1255;
  • You have access
    Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    R K Zalups, R M Gelein and M G Cherian
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1256-1266;
  • You have access
    Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
    C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;
  • You have access
    Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem.
    J C Louis, E Magal and S Varon
    Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1274-1283;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 262, Issue 3
1 Sep 1992
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics